| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $74,806,487 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI176776 | Synthesis and transport of outer membrane components across the Gram-negative cell envelope | 000 | 4 | NIH | 12/31/2025 | $640,850 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R33MH121560 | Cognitive Training for Emotion Regulation in Psychotic Disorders | 000 | 5 | NIH | 8/28/2026 | $549,411 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | K01AR082421 | Steps Towards OA Prevention | 001 | 4 | NIH | 8/6/2026 | $121,473 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL163256 | Effects of Early Life Exposure to Household Air Pollution on DNA Methylation and Respiratory Disease in Guatemalan Children from the Household Air Pollution Intervention Network (HAPIN) Trial | 001 | 4 | NIH | 8/4/2026 | $168,452 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL163256 | Effects of Early Life Exposure to Household Air Pollution on DNA Methylation and Respiratory Disease in Guatemalan Children from the Household Air Pollution Intervention Network (HAPIN) Trial | 000 | 4 | NIH | 5/27/2026 | $408,435 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA055630 | Early Adversity and Drug Use Vulnerability Among Low Income Rural Children: Testing a Neuro-ecological Model of Resilience | 001 | 4 | NIH | 2/11/2026 | $54,644 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA055630 | Early Adversity and Drug Use Vulnerability Among Low Income Rural Children: Testing a Neuro-ecological Model of Resilience | 000 | 4 | NIH | 2/5/2026 | $624,074 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI158743 | Synthetic multi-component influenza vaccines to elicit broad immunity | 000 | 3 | NIH | 1/6/2026 | $660,492 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HD114750 | Mechanisms of uterine fluid absorption during early pregnancy | 000 | 3 | NIH | 3/24/2026 | $637,476 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AA026362 | The Neurokinin-1 Receptor as a Mediator of Alcoholism and Depression Comorbidity | 000 | 8 | NIH | 5/5/2026 | $340,622 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AT012783 | Multi-omics approaches to lower the barriers to sustainable production of plant natural products with relevance to human health | 000 | 3 | NIH | 4/29/2026 | $523,612 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM152057 | Regulation of protein transport in cilia | 001 | 3 | NIH | 3/23/2026 | $54,481 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21TR005505 | Repurposing the PI3Kα inhibitor Alpelisib for the treatment of Multiple Hereditary Exostoses | 001 | 1 | NIH | 9/2/2026 | $415,250 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21TR005505 | Repurposing the PI3Kα inhibitor Alpelisib for the treatment of Multiple Hereditary Exostoses | 001 | 1 | NIH | 9/2/2026 | -$415,250 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21TR005505 | Repurposing the PI3Kα inhibitor Alpelisib for the treatment of Multiple Hereditary Exostoses | 000 | 1 | NIH | 4/27/2026 | $415,250 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | S10OD040213 | Sony SH800 Cell Sorter | 000 | 1 | NIH | 6/11/2026 | $317,073 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL178801 | Long Noncoding RNA Regulation in Complement-Mediated Endothelial Barrier Disruption: From Mechanism to Therapy | 000 | 1 | NIH | 8/3/2026 | $588,284 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI198196 | Pan-fungal vaccine development targeting recurrent vulvovaginal candidiasis | 000 | 1 | NIH | 7/9/2026 | $759,935 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | K01AI201974 | Strain-Resolved B. infantis Colonization and Consequences for Child Health | 000 | 1 | NIH | 8/26/2026 | $157,356 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI140719 | Cryptococcal vaccine development based on strong immunity induced by morphological strains | 000 | 8 | NIH | 4/24/2026 | $577,287 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31AI197783 | Elucidating the Role of the Naegleria fowleri secretome in a Host-Pathogen Context | 001 | 1 | NIH | 7/28/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31AI197783 | Elucidating the Role of the Naegleria fowleri secretome in a Host-Pathogen Context | 000 | 1 | NIH | 7/28/2026 | $50,114 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R33AI169204 | Novel Nanoparticle Respiratory Tract Mucosal Vaccine | 000 | 5 | NIH | 7/22/2026 | $391,920 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R33AI169204 | Novel Nanoparticle Respiratory Tract Mucosal Vaccine | 000 | 5 | NIH | 7/22/2026 | $391,919 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM158412 | Merging bacteriophage biology with microbial glycobiology | 000 | 2 | NIH | 6/19/2026 | $377,500 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG074216 | APOE4 effects on glia-neuron interaction in the olfactory bulb | 001 | 4 | NIH | 2/23/2026 | $45,020 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG074216 | APOE4 effects on glia-neuron interaction in the olfactory bulb | 000 | 4 | NIH | 2/12/2026 | $405,192 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM156839 | Chromosome-specific meiotic biology | 000 | 2 | NIH | 8/24/2026 | $363,917 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AR087085 | Molecular Mechanism of Human Myogenesis | 000 | 1 | NIH | 5/1/2026 | $614,390 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM163243 | DMS/NIGMS1: Unravel the connection between deformability and motility of eukaryotic cell through a | 000 | 2 | NIH | 7/22/2026 | $204,954 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R00HG013351 | Genomic basis of variation in the transcriptional response to pathogens among primates | 000 | 3 | NIH | 5/14/2026 | $248,943 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG077386 | Stress, Weathering, and Blood-Based Biomarkers of Alzheimer’s Disease | 000 | 3 | NIH | 6/8/2026 | $789,177 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI197097 | Establishing a cystic fibrosis ferret model of chronic Mycobacterium abscessus lung infection | 000 | 1 | NIH | 1/27/2026 | $224,857 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM159028 | Role of CTCF in Nucleotide Excision Repair | 000 | 1 | NIH | 3/6/2026 | $300,872 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | 90ZB0040 | Elevating Couple Relationships across Georgia is a campus-community initiative to strengthen families by enhancing the relationship skills and financial capability for at least 1,275 adult couples. | 01 | 2 | ACF | 9/24/2026 | $247,000 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | 90ZB0040 | Elevating Couple Relationships across Georgia is a campus-community initiative to strengthen families by enhancing the relationship skills and financial capability for at least 1,275 adult couples. | 00 | 2 | ACF | 8/27/2026 | $1,238,000 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI195147 | Immunity induced by cryptococcal morphological strains in CD4+ T cell-deficient hosts | 000 | 1 | NIH | 2/2/2026 | $400,932 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21MH143037 | Leveraging Technology to Improve Mental Health Access for Hard-to-Reach Young Populations | 000 | 1 | NIH | 7/29/2026 | $415,250 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01ES033892 | Microglial Hv1 Proton Channel as a Mediator of Environmentally-Induced Neuroinflammation and Neurodegeneration | 000 | 5 | NIH | 2/6/2026 | $600,217 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31HD119991 | Mutual communications between RhoA signaling and P4 signaling in luteal cells and the uterus during early pregnancy | 000 | 2 | NIH | 6/30/2026 | $44,279 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI187991 | Impact of breastmilk on Campylobacter jejuni survival | 000 | 2 | NIH | 7/15/2026 | $571,836 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI193123 | Memory Regulatory T cells in Recurring Malaria | 000 | 2 | NIH | 7/23/2026 | $650,020 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01CA299080 | Calcium Nanoparticles to Enhance Immuno-Radiotherapy | 000 | 1 | NIH | 3/24/2026 | $618,236 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31AI203011 | Consequences of genome content variation in the human fungal pathogen Cryptococcus neoformans | 000 | 1 | NIH | 9/1/2026 | $50,114 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM165843 | Modeling the Emergence Cascade: From Wildlife Pathogen Circulation to Human Outbreak Amplification | 000 | 1 | NIH | 7/16/2026 | $393,673 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM161349 | Glycosidase Inhibitors and Related Compounds | 000 | 1 | NIH | 7/15/2026 | $2,052,103 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM164352 | Somatic and germline fate decisions in dynamic stem cell utilization by tapeworms | 000 | 1 | NIH | 8/6/2026 | $442,250 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01CA314296 | Optimization of a public neoantigen-based cancer prevention strategy | 000 | 1 | NIH | 5/19/2026 | $659,570 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI202073 | Characterization of pan-fungal monoclonal antibodies targeting Aspergillus | 000 | 1 | NIH | 8/17/2026 | $228,000 |
|
